Fusion Pharm Inc (FSPM)

Currency in USD
0.0001
0.0000(0.00%)
Closed·

FSPM Financial Summary

Key Ratios

P/E Ratio-0
Price/Book-0
Debt / Equity-187.76%
Return on Equity678.32%
Dividend Yield0.00%
EBITDA-274.56K
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2005
31/12
2006
31/12
2010
31/12
2011
31/12
* In Millions of USD (except for per share items)

Earnings

Latest Release
Aug 20, 2013
EPS / Forecast
-- / --
Revenue / Forecast
330.30K / --
EPS Revisions
Last 90 days

FAQ

What were Fusion Pharm Inc's earnings for the latest quarter?

The Fusion Pharm Inc EPS (TTM) is -0.15. Fusion Pharm Inc reported sales of 0.07, net income of -0.09, and EPS of 0.00 for the latest quarter.

What was Fusion Pharm Inc's net income for the latest quarter?

Fusion Pharm Inc's net income for the latest quarter was -0.09.

How did Fusion Pharm Inc's performance compare year-over-year in the latest quarter?

The company's revenue moved from 0.13 in the previous quarter to 0.07 in the latest quarter, and net income moved from -0.14 to -0.09 compared to the previous quarter.

What is Fusion Pharm Inc's net profit margin on a TTM basis?

Fusion Pharm Inc's trailing twelve months (TTM) net profit margin is -111.94%.

How does Fusion Pharm Inc's debt to equity ratio compare to industry standards?

Fusion Pharm Inc's total debt-to-equity ratio is -187.76%.

What is Fusion Pharm Inc's return on investment on a TTM basis?

Fusion Pharm Inc's trailing twelve months (TTM) return on investment (ROI) is 678.32%.

Did Fusion Pharm Inc gain or lose cash last quarter?

In the latest quarter, Fusion Pharm Inc's net change in cash was -0.03 million.

What were Fusion Pharm Inc's total assets and liabilities in the latest quarter?

As of the latest quarter, Fusion Pharm Inc reported total assets of 0.16 million and total liabilities of 0.04 million.

How has Fusion Pharm Inc's total revenue grown this year?

Fusion Pharm Inc's total revenue was 0.13 in the previous quarter and 0.07 in the latest quarter.

What was Fusion Pharm Inc's revenue per share for the latest quarter?

Fusion Pharm Inc's revenue per share for the latest quarter was 72.28.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.